Schroy Paul C, Barrison Adam F, Ling Bruce S, Wilson Sheila, Geller Adam C
Department of Medicine, Boston University School of Medicine, Massachusetts, USA.
Am J Gastroenterol. 2002 Apr;97(4):1031-6. doi: 10.1111/j.1572-0241.2002.05624.x.
Risk stratification is essential to effective implementation of colorectal cancer (CRC) screening strategies. The objectives of this study were to assess and compare the current knowledge and practice patterns of gastroenterologists and primary care physicians regarding familial risk of CRC.
We conducted a survey of regional gastroenterologists and a sample of university- and community-based primary care physicians. The survey instrument assessed physician knowledge of screening recommendations and current practices for individuals with family histories of CRC, adenomatous polyps (APs), familial adenomatous polyposis (FAP), and hereditary nonpolyposis cancer (HNPCC). The instrument also elicited data about familial risk assessment, documentation, and notification of at-risk family members.
Thirty-five gastroenterologists (65%) and 58 primary care physicians (92%) completed the survey. Most gastroenterologists and primary care physicians (85% vs 72%) chose age 40 as the appropriate age to begin screening for a family history of CRC, but relatively few (37% vs 36%) recommended screening at age 40 for a family history of APs. Gastroenterologists were significantly more likely to recommend screening for FAP at puberty (80% vs 27%, p < 0.001) and for HNPCC at age 25 (73% vs 50%, p = 0.04). Colonoscopy was the preferred screening strategy by both groups for family histories of CRC (97%), HNPCC (97%), and APs (77%); primary care physicians also preferred colonoscopy for family histories of CRC (72%) and HNPCC (76%) but flexible sigmoidoscopy plus fecal occult blood testing for a family history of APs (38%). Gastroenterologists were more likely to recommend genetic testing for persons at risk of FAP (91% vs 71%, p = 0.03) and HNPCC (72% vs 57%, p = 0.18), routinely inquire about a family history of CRC or APs (93% vs 63%, p < 0.001), and recommend notification of at-risk first-degree relatives with family histories of CRC (94% vs 55%, p < 0.001) or AP (53% v.s 6%, p < 0.001).
Although gastroenterologists are more likely than primary care physicians to elicit a family history of colorectal neoplasia and implement appropriate screening strategies, overall compliance with recommended guidelines and notification of at-risk relatives are suboptimal. Novel approaches for improving awareness of the available screening guidelines are needed.
风险分层对于有效实施结直肠癌(CRC)筛查策略至关重要。本研究的目的是评估和比较胃肠病学家和初级保健医生关于CRC家族风险的当前知识和实践模式。
我们对地区胃肠病学家以及一组以大学和社区为基础的初级保健医生进行了调查。调查工具评估了医生对于CRC家族史、腺瘤性息肉(AP)、家族性腺瘤性息肉病(FAP)和遗传性非息肉病性结直肠癌(HNPCC)患者的筛查建议知识和当前实践。该工具还收集了有关家族风险评估、记录以及向高危家庭成员告知的相关数据。
35名胃肠病学家(65%)和58名初级保健医生(92%)完成了调查。大多数胃肠病学家和初级保健医生(85%对72%)选择40岁作为因CRC家族史开始筛查的合适年龄,但相对较少(37%对36%)的人建议因AP家族史在40岁时进行筛查。胃肠病学家更有可能建议在青春期对FAP进行筛查(80%对27%,p<0.001),在25岁时对HNPCC进行筛查(73%对50%,p = 0.04)。对于CRC家族史(97%)、HNPCC(97%)和AP(77%),结肠镜检查是两组首选的筛查策略;初级保健医生对于CRC家族史(72%)和HNPCC家族史(76%)也首选结肠镜检查,但对于AP家族史则更倾向于乙状结肠镜检查加粪便潜血试验(38%)。胃肠病学家更有可能建议对有FAP风险(91%对71%,p = 0.03)和HNPCC风险(72%对57%,p = 0.18)的人进行基因检测,常规询问CRC或AP家族史(93%对63%,p<0.001),并建议向有CRC家族史(94%对55%,p<0.001)或AP家族史(53%对6%,p<0.001)的高危一级亲属进行告知。
尽管胃肠病学家比初级保健医生更有可能询问结直肠肿瘤家族史并实施适当的筛查策略,但总体上对推荐指南的遵循情况以及向高危亲属的告知情况并不理想。需要采用新方法来提高对现有筛查指南的认识。